1. Meeting the Formidable Challenges of Strategic Sourcing: Building a Virtual Infrastructure for Drug Development and Commercialization
BSMA Panel - April 26, 2017
Moderator:
Mary Kachinsky
FORMA Therapeutics
VP Strategic Sourcing and Operations

2. Meet the Panel Members Matt Weinberg Director, Strategic Sourcing
Agios
10+ years’ strategic sourcing experience across diverse indirect categories
Procurement team leader for fast-growing biotech
Kimberly Lounds Foster
Corporate VP of Global Supply
Celgene
20+ years experience in pharma operations, merger & acquisitions, strategic planning
Experience from Big Pharma, Biotech, CAR-T, Generic and in contract manufacturing
Stephany Lapierre
Founder and CEO
tealbook
Entrepreneur with 15 years’ healthcare industry experience
Sourcing expert for 50 of the industry’s leading companies
Has efficiently managed more than 500 supplier searches across all healthcare functions
John Napoli
Director, Information Services, Perkin Elmer
Thought Leader, Strategist, Leader for cutting edge IT Managed Service Programs in the BioPharma industry
Business Process Transformation Change Manager
Specialist w/ 35 years experience in Platform Maturity for Lab
IT environments.

3. Access to Assets, Not Ownership of Assets
“Say I were to give you the following challenge: Create an organization that could compete head-to-head with any Fortune 500 company, without investing in any assets that you yourself owned. Thirty years ago, this would have been a preposterous proposition. Today, it is completely feasible. Increasingly, our world is one in which one pays for access to the assets one needs, rather than having to own them outright.”
Rita Gunther McGrath, The End of Competitive Advantage (2013), page 95.

4. Building a Virtual Competitive Advantage
Tap in to a broader network of providers
Harvest value through creative “deal making”
Engage in a collaborate partnership centered around trust
Hire a skilled team to manage your supply network
Create a culture that supports risk
Shift your thinking from a hierarchical to a symbiotic model
A well defined and orchestrated supply chain will minimize risk and maximize the the potential for competitive advantage.

5. Panel Questions & Discussion

6. Panel Members Matt Weinberg Director, Strategic Sourcing Agios
10+ years’ strategic sourcing experience across diverse indirect categories
Procurement team leader for fast-growing biotech
Kimberly Lounds Foster
Corporate VP of Global Supply
Celgene
20+ years experience in pharma operations, merger & acquisitions, strategic planning
Experience from Big Pharma, Biotech, CAR-T, Generic and in contract manufacturing
Stephany Lapierre
Founder and CEO
tealbook
Entrepreneur with 15 years’ healthcare industry experience
Sourcing expert for 50 of the industry’s leading companies
Has efficiently managed more than 500 supplier searches across all healthcare functions
John Napoli
Director, Information Services, Perkin Elmer
Thought Leader, Strategist, Leader for cutting edge IT Managed Service Programs in the BioPharma industry
Business Process Transformation Change Manager
Specialist w/ 35 years experience in Platform Maturity for Lab
IT environments.